RUO supplier
Official COA search and public batch reports reviewed
Deep research review
Simple Peptide publishes a public COA search and a Florida contact address. A reviewed GHRP-2 report names Freedom Diagnostics and exposes sample-level purity, identity, and net-content fields. The public search is JavaScript-driven, so current catalog coverage still needs a systematic crawl.
What this review did not check: One public report cannot establish current catalog-wide documentation coverage.
Active storefront observed
The official storefront, FAQ, and COA search were accessible on the review date.
A functioning storefront does not establish legal standing or manufacturing location.
Findings
Contact Disclosure
The site publishes 6586 W Atlantic Ave, Suite 1112, Delray Beach, Florida 33446, plus phone and email contact details.
Limit: The address is a contact address and should not be labeled as a manufacturing or laboratory facility without separate evidence.
Company Position
The site says products are RUO and that Simple Peptide is not a 503A compounding pharmacy or a 503B outsourcing facility.
Limit: This is the company's legal statement, not an agency determination.
Public Catalog
The catalog is publicly browseable and the FAQ says products are offered to qualified buyers.
Limit: The site says institutional or business details may be requested, but the gating process was not tested.
Searchable Public Interface
The public COA page provides search fields for product name, lot number, and accession number.
Limit: The result table is JavaScript-driven and was not exhaustively crawled.
Public sample report
A GHRP-2 10 mg report for lot GHRP2-022026 and accession 2602270028 reports 12.67 mg net content, 99.94% purity, GHRP-2 identity, and white lyophilized appearance.
Limit: The report is sample-specific and says integrity, handling, and other variables may affect results.
Named relationships
named-on-public-sample-report
Limit: One report does not establish that the laboratory tests every current lot.
Search limits
Limited regulatory search
No exact-name FDA warning letter, recall, or enforcement page surfaced in the limited FDA-site search.
Limit: Search absence is not regulatory clearance.
No substantive indexed discussion found
No substantive exact-name Reddit thread surfaced in the indexed search used for this review.
Limit: Search absence is not evidence of reputation.
Open company questions
Observable documentation fields
This measures fields in normalized public records. It does not score product quality, sterility, legal compliance, or suitability.
Normalized batch records
Each row becomes a stacked record on smaller screens. Coverage means the field appears in the source record. It is not a Peptide Report pass or independent reproduction.
| Product | Batch | Laboratory | Date | Methods | Fields present | Record |
|---|---|---|---|---|---|---|
| BPC-157 15 mg research material | BPC15-01092026-J | Freedom Diagnostics Testing | Mar 21, 2026 | HPLC, LC-MS, Endotoxin | identity, purity, net Content, endotoxin | Source report |
| GHRP-2 10 mg research material | GHRP2-022026 | Freedom Diagnostics Testing | Feb 28, 2026 | HPLC, LC-MS | identity, purity, net Content | Source report |
Observed catalog records
Compound page not yet normalized
Source recordThe COA search exposes batch records and a public business address. Individual reports still apply only to the listed sample and lot.
Profile ownership: unclaimed. Company representatives will be able to propose identity and catalog updates without changing editorial or regulatory records.
These secondary directories helped identify the company. Their rankings and verification labels are not adopted by Peptide Report.